Coronavirus: Remdesivir has 'little effect' on death risks, says WHO

The WHO's 11,266-person trial found no significant reduction in mortality risks among hospitalized COVID-19 patients treated with remdesivir, lopinavir, interferon or hydroxychloroquine
Source: the Mail online | Health - Category: Consumer Health News Source Type: news